Growth failure in children with cystic fibrosis.

Alessandra Scaparrotta, Sabrina Di Pillo, Marina Attanasi, Nicola Pietro Consilvio, Anna Cingolani, Daniele Rapino, Angelika Mohn, Francesco Chiarelli

Journal: Journal of pediatric endocrinology & metabolism : JPEM 2012;25(5-6):393-405

PMID: 22876530

Abstract

Poor linear growth and inadequate weight gain are very common problems in cystic fibrosis (CF) children. The most important factors involved in growth failure are undernutrition or malnutrition, chronic inflammation, lung disease, and corticosteroid treatment. Nutritional support and pharmacological therapy with recombinant human growth hormone are essential for a good management of children with CF, although these children are shorter and lighter than healthy children, and despite the catch-up growth observed after diagnosis, deficit in length/height and weight continues to be seen until adulthood. Early diagnosis is essential to ensure better nutritional status and growth, potentially associated with better respiratory function and prognosis. The aims of this review are try to explain etiology and pathogenetic mechanisms of growth failure in CF children and clarify their role in the disease morbidity and in clinical outcome, especially in relation to progressive decline of pulmonary function.

Address: Department of Pediatrics, University of Chieti, Italy. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.